<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Epidemiol.</journal-id>
<journal-title>Frontiers in Epidemiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Epidemiol.</abbrev-journal-title>
<issn pub-type="epub">2674-1199</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fepid.2025.1480372</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Epidemiology</subject>
<subj-group>
<subject>General Commentary</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Commentary: Oil and gas development exposure and atrial fibrillation exacerbation: a retrospective study of atrial fibrillation exacerbation using Colorado&#x0027;s all payer claims dataset</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Wendt Hess</surname><given-names>Judy</given-names></name>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2816648/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff><institution>Hess Epidemiology Services LLC</institution>, <addr-line>Houston, TX</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Morteza Abdullatif Khafaie, Ahvaz Jundishapur University of Medical Sciences, Iran</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Morufu Olalekan Raimi, Federal University, Nigeria</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Judy Wendt Hess <email>episervices@proton.me</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>10</day><month>02</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>5</volume><elocation-id>1480372</elocation-id>
<history>
<date date-type="received"><day>13</day><month>08</month><year>2024</year></date>
<date date-type="accepted"><day>13</day><month>01</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Wendt Hess.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Wendt Hess</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<kwd-group>
<kwd>atrial fibrillation</kwd>
<kwd>survival analysis</kwd>
<kwd>interrupted time series</kwd>
<kwd>oil and gas development</kwd>
<kwd>Colorado (USA)</kwd>
</kwd-group><counts>
<fig-count count="1"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="12"/><page-count count="3"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Occupational and Environmental Epidemiology</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Epidemiol." journal-id-type="nlm-ta" xlink:href="10.3389/fepid.2024.1379271" ext-link-type="doi">A Commentary on <article-title>Oil and gas development exposure and atrial fibrillation exacerbation: a retrospective study of atrial fibrillation exacerbation using Colorado&#x2019;s all payer claims dataset</article-title> By McKenzie LM, Allshouse WB, Abrahams B and Tompkins C (2024). Front. Epidemiol. 4:1379271. doi: <object-id>10.3389/fepid.2024.1379271</object-id></related-article>
<sec id="s1" sec-type="intro"><title>Introduction</title>
<p>McKenzie et al. (<xref ref-type="bibr" rid="B1">1</xref>) recently evaluated whether individuals with pre-existing atrial fibrillation (AF) or atrial flutter (AFl) living within 1&#x2005;mile of an oil and gas (O&#x0026;G) well were more likely to experience a healthcare encounter for AF/AFl during or after, compared to before, well development. The analysis used 2009&#x2013;2017 data from Colorado&#x0027;s All Payer Claims Database (APCD) (<xref ref-type="bibr" rid="B2">2</xref>), representing nearly two-thirds of the state&#x0027;s insured residents.</p>
<p>The study was described as a quasi-experimental interrupted time series (ITS); however, it did not satisfy ITS design characteristics or statistical requirements, and to describe it as such ascribes rigor to the analysis that the structure of the data was unable to provide. The paper further detailed the use of survival analysis (SA), but again, the analysis did not include critical elements of this statistical approach.</p>
<p>Readers who have less familiarity with these statistical techniques may take these study results at face value, without understanding that the authors applied what are perceived as rigorous methods to data that were not suited for them. The methodological issues with this analysis, discussed below, should be addressed by the authors before the study is accepted as epidemiological evidence that nearby O&#x0026;G activity increases the risk of AF/AFl.</p>
</sec>
<sec id="s2"><title>Interrupted time series</title>
<p>ITS is the real-world analog to a randomized controlled trial (RCT) (<xref ref-type="bibr" rid="B3">3</xref>). As described in papers cited by McKenzie et al., ITS evaluates the impact of an intervention introduced to a specific population at a clearly defined point in time, effectively controlling for between-group differences and underlying time trends in the outcome (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). The objective is to describe whether increased disease occurrence coincided with the start of the intervention (<xref ref-type="bibr" rid="B6">6</xref>). Results are typically reported as the average number or rate of health events before and after the intervention (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>The authors chose the ITS design because it allowed for control of potential confounders unavailable in the APCD. However, this feature of ITS hinges on the intervention beginning and ending at approximately the same time across the study population, similar to RCT participants. The intervention in this study was the development of a well within 1&#x2005;mile of a home address, starting with the spud date and ending on the first day of production. This &#x201C;during&#x201D; drilling (i.e., intervention) period was highly variable across study participants, ranging from 3 to 844&#x2005;days. Periods &#x201C;before&#x201D; and &#x201C;after&#x201D; the intervention were the same duration as the &#x201C;during&#x201D; period, but one before the spud date and the other after the first production date. Thus, follow-up periods including before, during, and after drilling for the nearly 1,200 study participants were as short as 9&#x2005;days for some and over 2,500&#x2005;days for others, staggered across the 9-year study period. While statistical approaches to analyze multiple baseline time series data exist, they cannot accommodate both staggered intervention start dates and widely varying follow-up time across the study population (<xref ref-type="bibr" rid="B8">8</xref>).</p>
</sec>
<sec id="s3"><title>Survival analysis</title>
<p>The authors do not explain why multi-failure SA was used, which is not a typical or recommended statistical method for ITS (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). The study reported hazard ratios&#x2014;the estimate of risk produced by SA&#x2014;comparing the risk of AF/AFl encounters during vs. before drilling and after vs. before drilling.</p>
<p>SA requires calculating the observed person-time for each participant (<xref ref-type="bibr" rid="B11">11</xref>) based on the period of time he or she was &#x201C;at risk&#x201D; of a recorded AF/AFl encounter, which presumes presence in the APCD with no gaps in coverage. Person-time could almost certainly have been derived from beneficiary enrollment dates in the APCD; however, no description of this was included in the paper. Rather, it appears that at-risk and control patients were assumed to be present in the APCD for the entirety of their follow-up periods.</p>
<p>More concerning was the exclusion of half the at-risk patients from the analysis &#x201C;to reduce errors from unknown losses to follow-up.&#x201D; McKenzie et al. describe these participants in their text as &#x201C;without a claim of any type preceding the before period and succeeding the after period,&#x201D; and alternatively in their Figure&#x00A0;2 as &#x201C;without evidence of presence in APCD through follow-up&#x201D; (<xref ref-type="bibr" rid="B1">1</xref>). However, since an AF/AFl diagnosis between 2009 and 2017 (but before the end of follow-up) was required for study eligibility, and the same APCD enrollment file from which the authors obtained address, gender, and birth date also included enrollment dates, the reason for excluding these patients is unclear. Excluding those with no claims during follow-up from the at-risk population would effectively inflate hazard ratios by removing person-time from the denominator that did not add any AF/AFl events to the numerator.</p>
<p>Finally, the lack of covariate data in the APCD, while not required for ITS, is required for SA, particularly when participant follow-up time is variable and not temporally aligned. Although the study included controls, this could not account for factors that varied with time because the controls were matched to at-risk patients not by calendar year, but rather by region of residence in the state and year of first AF/AFl diagnosis in the APCD. In addition to seasonal trends and increasing AF prevalence during the 9-year study period (<xref ref-type="bibr" rid="B12">12</xref>), technological, regulatory, and economic factors likely impacted underlying trends in noise and air pollution exposure resulting from nearby drilling over time.</p>
</sec>
<sec id="s4" sec-type="conclusions"><title>Conclusion</title>
<p>The question addressed in the study by McKenzie et al.&#x2014;whether close proximity drilling exacerbates existing AF/AFl, and if so, whether certain demographic groups are particularly susceptible&#x2014;is an important one that has not been previously addressed. The design of the study was novel, and the dataset used in their analysis is a rich source of claims data from a state with considerable O&#x0026;G activity.</p>
<p>The authors state in their conclusion: &#x201C;these findings support development of mitigation strategies and regulations to protect the health of populations living near O&#x0026;G well sites.&#x201D; The methodological issues described above, however, are significant and raise concerns about the validity and interpretation of the reported results. Given the importance of this topic, and potential implications for public health practitioners and policymakers, I encourage the authors to address these methodological issues in any further research they conduct on this topic.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="author-contributions"><title>Author contributions</title>
<p>JWH: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s6" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec id="s7" sec-type="COI-statement"><title>Conflict of interest</title>
<p>JWH was employed by Shell Oil Company, and has consulted to oil and gas companies and trade associations.</p>
</sec>
<sec id="s8" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>LM</given-names></name><name><surname>Allshouse</surname><given-names>WB</given-names></name><name><surname>Abrahams</surname><given-names>B</given-names></name><name><surname>Tompkins</surname><given-names>C</given-names></name></person-group>. <article-title>Oil and gas development exposure and atrial fibrillation exacerbation: a retrospective study of atrial fibrillation exacerbation using Colorado&#x0027;s all payer claims&#x00A0;dataset</article-title>. <source>Front Epidemiol</source>. (<year>2024</year>) <volume>4</volume>:<fpage>1379271</fpage>. <pub-id pub-id-type="doi">10.3389/fepid.2024.1379271</pub-id><pub-id pub-id-type="pmid">38962693</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="book"><collab>Center for Improving Value in Health Care</collab>. <source>CO APCD Info</source>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://civhc.org/get-data/co-apcd-info/">https://civhc.org/get-data/co-apcd-info/</ext-link> (<comment>Accessed August 12, 2024</comment>)</citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kontopantelis</surname><given-names>E</given-names></name><name><surname>Doran</surname><given-names>T</given-names></name><name><surname>Springate</surname><given-names>DA</given-names></name><name><surname>Buchan</surname><given-names>I</given-names></name><name><surname>Reeves</surname><given-names>D</given-names></name></person-group>. <article-title>Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis</article-title>. <source>BMJ</source>. (<year>2015</year>) <volume>350</volume>:<fpage>h2750</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.h2750</pub-id><pub-id pub-id-type="pmid">26058820</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernal</surname><given-names>JL</given-names></name><name><surname>Cummins</surname><given-names>S</given-names></name><name><surname>Gasparrini</surname><given-names>A</given-names></name></person-group>. <article-title>Interrupted time series regression for the evaluation of public health interventions: a tutorial</article-title>. <source>Int J Epidemiol</source>. (<year>2017</year>) <volume>46</volume>(<issue>1</issue>):<fpage>348</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyw098</pub-id><pub-id pub-id-type="pmid">27283160</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez Bernal</surname><given-names>J</given-names></name><name><surname>Cummins</surname><given-names>S</given-names></name><name><surname>Gasparrini</surname><given-names>A</given-names></name></person-group>. <article-title>The use of controls in interrupted time series studies of public health interventions</article-title>. <source>Int J Epidemiol</source>. (<year>2018</year>) <volume>47</volume>(<issue>6</issue>):<fpage>2082</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyy135</pub-id><pub-id pub-id-type="pmid">29982445</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>A</given-names></name><name><surname>Soumerai</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Ross-Degnan</surname><given-names>D</given-names></name></person-group>. <article-title>Segmented regression analysis of interrupted time series studies in medication use research</article-title>. <source>J Clin Pharm Ther</source>. (<year>2002</year>) <volume>27</volume>(<issue>4</issue>):<fpage>299</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2710.2002.00430.x</pub-id><pub-id pub-id-type="pmid">12174032</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>N</given-names></name><name><surname>Steyn</surname><given-names>P</given-names></name><name><surname>Boydell</surname><given-names>V</given-names></name><name><surname>Cordero</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Thwin</surname><given-names>S</given-names></name><etal/></person-group> <article-title>The use of segmented regression for evaluation of an interrupted time series study involving complex intervention: the CaPSAI project experience</article-title>. <source>Health Serv Outcomes Res Methodol</source>. (<year>2021</year>) <volume>21</volume>(<issue>2</issue>):<fpage>188</fpage>&#x2013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1007/s10742-020-00221-9</pub-id><pub-id pub-id-type="pmid">34720688</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biglan</surname><given-names>A</given-names></name><name><surname>Ary</surname><given-names>D</given-names></name><name><surname>Wagenaar</surname><given-names>AC</given-names></name></person-group>. <article-title>The value of interrupted time-series experiments for community intervention research</article-title>. <source>Prev Sci</source>. (<year>2000</year>) <volume>1</volume>(<issue>1</issue>):<fpage>31</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1023/A:1010024016308</pub-id><pub-id pub-id-type="pmid">11507793</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hategeka</surname><given-names>C</given-names></name><name><surname>Ruton</surname><given-names>H</given-names></name><name><surname>Karamouzian</surname><given-names>M</given-names></name><name><surname>Lynd</surname><given-names>LD</given-names></name><name><surname>Law</surname><given-names>MR</given-names></name></person-group>. <article-title>Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review</article-title>. <source>BMJ Glob Health</source>. (<year>2020</year>) <volume>5</volume>(<issue>10</issue>):<fpage>e003567</fpage>. <pub-id pub-id-type="doi">10.1136/bmjgh-2020-003567</pub-id><pub-id pub-id-type="pmid">33055094</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewusie</surname><given-names>JE</given-names></name><name><surname>Soobiah</surname><given-names>C</given-names></name><name><surname>Blondal</surname><given-names>E</given-names></name><name><surname>Beyene</surname><given-names>J</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Hamid</surname><given-names>JS</given-names></name></person-group>. <article-title>Methods, applications and challenges in the analysis of interrupted time series data: a scoping review</article-title>. <source>J Multidiscip Healthc</source>. (<year>2020</year>) <volume>13</volume>:<fpage>411</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.2147/JMDH.S241085</pub-id><pub-id pub-id-type="pmid">32494150</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sainani</surname><given-names>KL</given-names></name></person-group>. <article-title>Introduction to survival analysis</article-title>. <source>PM&#x0026;R</source>. (<year>2016</year>) <volume>8</volume>:<fpage>580</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.pmrj.2016.04.003</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colilla</surname><given-names>S</given-names></name><name><surname>Crow</surname><given-names>A</given-names></name><name><surname>Petkun</surname><given-names>W</given-names></name><name><surname>Singer</surname><given-names>DE</given-names></name><name><surname>Simon</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group>. <article-title>Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. Adult population</article-title>. <source>Am J Cardiol</source>. (<year>2013</year>) <volume>112</volume>(<issue>8</issue>):<fpage>1142</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2013.05.063</pub-id><pub-id pub-id-type="pmid">23831166</pub-id></citation></ref></ref-list>
</back>
</article>